JP2022046669A5 - - Google Patents

Download PDF

Info

Publication number
JP2022046669A5
JP2022046669A5 JP2021211779A JP2021211779A JP2022046669A5 JP 2022046669 A5 JP2022046669 A5 JP 2022046669A5 JP 2021211779 A JP2021211779 A JP 2021211779A JP 2021211779 A JP2021211779 A JP 2021211779A JP 2022046669 A5 JP2022046669 A5 JP 2022046669A5
Authority
JP
Japan
Prior art keywords
sample
assay
subject
recovery
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021211779A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022046669A (ja
JP7217796B2 (ja
Filing date
Publication date
Priority claimed from JP2020185705A external-priority patent/JP7002623B2/ja
Application filed filed Critical
Publication of JP2022046669A publication Critical patent/JP2022046669A/ja
Publication of JP2022046669A5 publication Critical patent/JP2022046669A5/ja
Priority to JP2023008480A priority Critical patent/JP2023052587A/ja
Application granted granted Critical
Publication of JP7217796B2 publication Critical patent/JP7217796B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021211779A 2014-10-20 2021-12-27 腎障害および腎不全の診断および予後のための方法および組成物 Active JP7217796B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023008480A JP2023052587A (ja) 2014-10-20 2023-01-24 腎障害および腎不全の診断および予後のための方法および組成物

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201462066310P 2014-10-20 2014-10-20
US201462066313P 2014-10-20 2014-10-20
US201462066316P 2014-10-20 2014-10-20
US62/066,316 2014-10-20
US62/066,310 2014-10-20
US62/066,313 2014-10-20
JP2020185705A JP7002623B2 (ja) 2014-10-20 2020-11-06 腎障害および腎不全の診断および予後のための方法および組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020185705A Division JP7002623B2 (ja) 2014-10-20 2020-11-06 腎障害および腎不全の診断および予後のための方法および組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023008480A Division JP2023052587A (ja) 2014-10-20 2023-01-24 腎障害および腎不全の診断および予後のための方法および組成物

Publications (3)

Publication Number Publication Date
JP2022046669A JP2022046669A (ja) 2022-03-23
JP2022046669A5 true JP2022046669A5 (https=) 2022-07-08
JP7217796B2 JP7217796B2 (ja) 2023-02-03

Family

ID=55761743

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2017521231A Active JP6792553B2 (ja) 2014-10-20 2015-10-20 腎障害および腎不全の診断および予後のための方法および組成物
JP2020185705A Active JP7002623B2 (ja) 2014-10-20 2020-11-06 腎障害および腎不全の診断および予後のための方法および組成物
JP2021211779A Active JP7217796B2 (ja) 2014-10-20 2021-12-27 腎障害および腎不全の診断および予後のための方法および組成物
JP2023008480A Pending JP2023052587A (ja) 2014-10-20 2023-01-24 腎障害および腎不全の診断および予後のための方法および組成物

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2017521231A Active JP6792553B2 (ja) 2014-10-20 2015-10-20 腎障害および腎不全の診断および予後のための方法および組成物
JP2020185705A Active JP7002623B2 (ja) 2014-10-20 2020-11-06 腎障害および腎不全の診断および予後のための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023008480A Pending JP2023052587A (ja) 2014-10-20 2023-01-24 腎障害および腎不全の診断および予後のための方法および組成物

Country Status (13)

Country Link
US (2) US11333671B2 (https=)
EP (2) EP3210018B1 (https=)
JP (4) JP6792553B2 (https=)
KR (1) KR102431003B1 (https=)
CN (2) CN110702921B (https=)
AU (2) AU2015336069B2 (https=)
BR (1) BR112017008218A2 (https=)
CA (1) CA2965153C (https=)
EA (1) EA201790696A1 (https=)
ES (1) ES2907551T3 (https=)
MX (1) MX388231B (https=)
PT (1) PT3210018T (https=)
WO (1) WO2016064877A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2965153C (en) 2014-10-20 2023-10-24 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP4063853A1 (en) * 2017-01-12 2022-09-28 Astute Medical, Inc. Methods and compositions for evaluation and treatment of renal injury and renal failure based on c-c motif chemokine ligand 14 measurement
CN110431422A (zh) 2017-02-06 2019-11-08 机敏医药股份有限公司 用于肾损伤和肾衰竭的诊断和预后的方法和组合物
US11891439B2 (en) 2017-12-28 2024-02-06 Astute Medical, Inc. Antibodies and assays for CCL14
US12114978B2 (en) 2018-04-02 2024-10-15 Potrero Medical, Inc. Systems, devices and methods for draining and analyzing bodily fluids and assessing health
CN119454032A (zh) * 2018-04-02 2025-02-18 波特雷罗医疗公司 用于排出和分析体液并评估健康的系统、设备和方法
CN114207436A (zh) * 2019-05-24 2022-03-18 机敏医药股份有限公司 基于c-c基序趋化因子配体14测量而评估和治疗肾损伤的方法
US20230290457A1 (en) * 2020-03-23 2023-09-14 Biocogniv Inc. Artificial intelligence medical device
GB2596142B (en) * 2020-06-19 2023-11-29 Secr Defence Methods and associated uses, kits and systems for assessing sepsis
EP4247395A4 (en) * 2020-11-18 2024-09-18 Astute Medical, Inc. Methods and compositions for treatment of renal injury and renal failure
CA3253529A1 (en) * 2022-03-03 2023-09-07 Astute Medical, Inc. METHODS AND COMPOSITIONS FOR EVALUATING AND TREATING PERSISTENT ACUTE RENAL INJURY BASED ON A C-C MOTIFYING CHEMOKIN LIGAND MEASUREMENT 14

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5028535A (en) 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
CA2072758A1 (en) 1990-09-14 1992-03-15 Kenneth Francis Buechler Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
US5955377A (en) 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
AU1772992A (en) 1991-04-10 1992-11-17 Biosite Diagnostics Incorporated Crosstalk inhibitors and their uses
JP3290988B2 (ja) 1991-04-11 2002-06-10 バイオサイト・ダイアグノスティックス・インコーポレイテッド 多重リガンドを同時検出する新規接合体及び検定法
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US5885527A (en) 1992-05-21 1999-03-23 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membrances
US5494829A (en) 1992-07-31 1996-02-27 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5824799A (en) 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US6811773B1 (en) 1993-12-22 2004-11-02 Human Genome Sciences, Inc. Human monocyte colony inhibitory factor (M-CIF) polypeptides
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
US6057098A (en) 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
AU2003223172A1 (en) 2002-02-12 2003-09-04 Quark Biotech, Inc. Use of the axl receptor for diagnosis and treatment of renal disease
US20120064089A1 (en) * 2002-11-15 2012-03-15 Morehouse School Of Medicine Anti-cxcl16 and anti-cxcr6 antibodies for the prevention and treatment of cancer and cancer cell migration
EP1915614A4 (en) 2005-07-21 2009-03-25 Univ Johns Hopkins METHOD FOR DETECTING AND TREATING AN ACUTE KIDNEY INJURY
WO2007035843A2 (en) * 2005-09-21 2007-03-29 Dask Technologies, Llc Methods and compositions for organ and tissue functionality
US20110059537A1 (en) 2007-09-20 2011-03-10 Caritas St. Elizabeth's Medical Center Of Boston, Inc. Method for estimating risk of acute kidney injury
WO2009114110A1 (en) 2008-03-08 2009-09-17 Immungene, Inc. Engineered fusion molecules immunotherapy in cancer and inflammatory diseases
CA2740923A1 (en) * 2008-10-21 2010-04-29 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2462437A4 (en) * 2009-08-07 2013-01-30 Rules Based Medicine Inc METHOD AND DEVICES FOR DETECTING DIABETIC NEPHROPATHY AND ASSOCIATED DISEASES THEREOF
CA2774223A1 (en) 2009-09-21 2011-03-24 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2010315008B2 (en) 2009-11-07 2015-12-03 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ600160A (en) * 2009-11-07 2014-05-30 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20120156701A1 (en) * 2009-12-20 2012-06-21 Joseph Anderberg Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2011075744A1 (en) 2009-12-20 2011-06-23 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2011213684B2 (en) * 2010-02-05 2014-11-20 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ605698A (en) 2010-06-23 2015-03-27 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
IN2012MN02812A (https=) * 2010-06-23 2015-05-22 Astute Medical Inc
NZ606124A (en) * 2010-06-23 2015-05-29 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
UY33492A (es) * 2010-07-09 2012-01-31 Abbott Lab Inmunoglobulinas con dominio variable dual y usos de las mismas
WO2012136548A1 (en) 2011-04-04 2012-10-11 Universiteit Gent Biomarkers for acute kidney injury
PT2748605T (pt) 2011-08-26 2019-05-03 Astute Medical Inc Processos e composições para o diagnóstico e o prognóstico de lesões renais e de insuficiência renal
US10935548B2 (en) * 2011-12-08 2021-03-02 Astute Medical, Inc. Methods for diagnosis and prognosis of renal injury and renal failure using insulin-like growth factor-binding protein 7 and metalloproteinase inhibitor 2
WO2013096740A1 (en) * 2011-12-21 2013-06-27 Alere San Diego Inc. Methods and compositions for assigning likelihood of chronic kidney disease progression
EP2962109A4 (en) 2013-02-26 2016-12-07 Astute Medical Inc METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
CA2965153C (en) 2014-10-20 2023-10-24 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Similar Documents

Publication Publication Date Title
JP2022046669A5 (https=)
NO20076656L (no) Forbedrede immunoassay metoder
CN111033237B (zh) 使用剂量响应曲线的递减信号部分来测量包括高浓度分析物在内的分析物的夹心式测定
JP2022091846A5 (https=)
JP5553615B2 (ja) プロゾーン現象の低減を示すイムノアッセイ
WO2017015132A1 (en) Chips, detectors, and methods of making and using the same
KR102425258B1 (ko) 검체 수집 및 분석 일체형 디바이스, 및 이를 이용한 질병 진단용 정보 제공 방법
DK1739430T3 (da) Fremgangsmåde til assay af cardiovaskulære sygdomme
JP6440719B2 (ja) 腎疾患のバイオマーカー
JP2020504157A5 (https=)
CN105021827B (zh) 检测血清血管生成素样蛋白2含量的物质在制备检测肝脏炎症和纤维化程度产品中的应用
WO2015192854A2 (en) Methods and tools for predicting steatohepatitis
CN204989196U (zh) 抗核抗体六项联合免疫层析定性检测试纸条
JP2024061719A (ja) ウイルス感染と細菌感染を区別するためのマルチプレックスラテラルフローアッセイ
Hassan et al. Pleural fluid analysis: standstill or a work in progress?
JP2021510815A5 (https=)
CN106153923B (zh) 预测谷丙转氨酶小于二倍正常上限的慢性乙型病毒性肝炎患者肝脏炎症程度的系统
Khashayar et al. PoCOsteo: generic novel platform for bone turnover marker measurement & monitoring
CN115980369A (zh) 一种基于炎症反应分型的过敏原筛查试剂盒及其应用
RU2008130888A (ru) Мас-2вр как маркер для диагностики рака желудка
CN202101997U (zh) 快速诊断急性心肌梗死的检测装置
JP2008180543A (ja) 分離デバイス、血液成分測定デバイス、血液成分測定システム、分離機能物質、血液成分測定方法、および分離方法。
RU2008139607A (ru) Новый анализ для обнаружения антитела, связанного с мембранным рецептором клетки
CN204287201U (zh) 中性粒细胞明胶酶相关载脂蛋白免疫层析检测试纸条
CN220525831U (zh) MxA/CRP检测试剂卡及试剂盒